Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anorexia Nervosa | 113 | 2024 | 1361 | 14.300 |
Why?
|
Bone Density | 125 | 2023 | 3551 | 12.300 |
Why?
|
Amenorrhea | 39 | 2023 | 483 | 10.530 |
Why?
|
Bone and Bones | 51 | 2023 | 2568 | 7.650 |
Why?
|
Athletes | 30 | 2023 | 1136 | 5.530 |
Why?
|
Absorptiometry, Photon | 58 | 2023 | 1737 | 3.810 |
Why?
|
Human Growth Hormone | 26 | 2020 | 638 | 3.430 |
Why?
|
Ghrelin | 23 | 2024 | 252 | 3.350 |
Why?
|
Gastrectomy | 18 | 2024 | 672 | 2.920 |
Why?
|
Obesity, Morbid | 11 | 2024 | 1277 | 2.700 |
Why?
|
Insulin-Like Growth Factor I | 34 | 2021 | 1931 | 2.590 |
Why?
|
Hydrocortisone | 23 | 2024 | 1815 | 2.590 |
Why?
|
Menstruation | 10 | 2019 | 307 | 2.560 |
Why?
|
Body Composition | 47 | 2024 | 2422 | 2.550 |
Why?
|
Radius | 16 | 2023 | 441 | 2.550 |
Why?
|
Adolescent | 202 | 2024 | 88313 | 2.460 |
Why?
|
Sports | 11 | 2021 | 705 | 2.410 |
Why?
|
Estrogens | 11 | 2023 | 1522 | 2.380 |
Why?
|
Peptide YY | 16 | 2024 | 136 | 2.360 |
Why?
|
Estrogen Replacement Therapy | 9 | 2021 | 1208 | 2.320 |
Why?
|
Estradiol | 25 | 2023 | 1937 | 2.210 |
Why?
|
Bone Remodeling | 9 | 2022 | 581 | 2.070 |
Why?
|
Osteoporosis | 14 | 2021 | 1605 | 2.020 |
Why?
|
Oxytocin | 10 | 2024 | 402 | 1.980 |
Why?
|
Obesity | 39 | 2024 | 12938 | 1.980 |
Why?
|
Fractures, Bone | 14 | 2023 | 2046 | 1.950 |
Why?
|
Leptin | 21 | 2023 | 1597 | 1.860 |
Why?
|
Young Adult | 126 | 2024 | 59207 | 1.820 |
Why?
|
Female Athlete Triad Syndrome | 8 | 2022 | 62 | 1.800 |
Why?
|
Oligomenorrhea | 3 | 2019 | 42 | 1.740 |
Why?
|
Adipose Tissue | 19 | 2021 | 3312 | 1.690 |
Why?
|
Tibia | 14 | 2023 | 1070 | 1.670 |
Why?
|
Estrone | 2 | 2023 | 234 | 1.590 |
Why?
|
Bone Diseases | 4 | 2021 | 418 | 1.570 |
Why?
|
Bariatric Surgery | 8 | 2024 | 992 | 1.540 |
Why?
|
Bone Marrow | 8 | 2021 | 2910 | 1.360 |
Why?
|
Hypothalamo-Hypophyseal System | 8 | 2016 | 700 | 1.330 |
Why?
|
Gastric Bypass | 5 | 2024 | 818 | 1.320 |
Why?
|
Female | 233 | 2024 | 392581 | 1.200 |
Why?
|
Pituitary-Adrenal System | 7 | 2016 | 551 | 1.130 |
Why?
|
Appetite | 6 | 2024 | 247 | 1.130 |
Why?
|
Body Weight | 28 | 2020 | 4618 | 1.130 |
Why?
|
Puberty, Precocious | 3 | 2022 | 164 | 1.120 |
Why?
|
Puberty | 8 | 2013 | 501 | 1.120 |
Why?
|
Spine | 10 | 2023 | 1118 | 1.080 |
Why?
|
Humans | 289 | 2024 | 761423 | 1.060 |
Why?
|
Growth Disorders | 8 | 2019 | 653 | 1.030 |
Why?
|
Hypothalamic Diseases | 4 | 2022 | 134 | 1.030 |
Why?
|
Cosyntropin | 2 | 2015 | 34 | 1.000 |
Why?
|
Vitamin D | 13 | 2019 | 3301 | 0.990 |
Why?
|
Feeding Behavior | 8 | 2019 | 3187 | 0.990 |
Why?
|
Child | 90 | 2024 | 80162 | 0.970 |
Why?
|
Body Mass Index | 41 | 2024 | 12951 | 0.970 |
Why?
|
Endocrinology | 4 | 2023 | 442 | 0.960 |
Why?
|
Polycystic Ovary Syndrome | 4 | 2016 | 376 | 0.950 |
Why?
|
Procollagen | 6 | 2020 | 187 | 0.940 |
Why?
|
Adolescent Development | 5 | 2020 | 282 | 0.930 |
Why?
|
Peptide Hormones | 7 | 2006 | 132 | 0.920 |
Why?
|
Cross-Sectional Studies | 53 | 2023 | 26112 | 0.860 |
Why?
|
Adrenal Insufficiency | 2 | 2015 | 194 | 0.850 |
Why?
|
Weight Gain | 11 | 2023 | 2347 | 0.850 |
Why?
|
Vitamin D Deficiency | 4 | 2019 | 1386 | 0.850 |
Why?
|
Lumbar Vertebrae | 11 | 2023 | 1881 | 0.840 |
Why?
|
Punishment | 1 | 2023 | 95 | 0.820 |
Why?
|
Weight Loss | 11 | 2024 | 2683 | 0.770 |
Why?
|
Intra-Abdominal Fat | 4 | 2011 | 612 | 0.760 |
Why?
|
Thinness | 8 | 2024 | 490 | 0.760 |
Why?
|
Luteinizing Hormone | 3 | 2013 | 820 | 0.740 |
Why?
|
Adult | 107 | 2024 | 221148 | 0.720 |
Why?
|
Testosterone | 14 | 2023 | 2472 | 0.710 |
Why?
|
Neurosecretory Systems | 2 | 2014 | 223 | 0.710 |
Why?
|
Insulin Resistance | 8 | 2023 | 3963 | 0.700 |
Why?
|
Exercise | 13 | 2021 | 5884 | 0.700 |
Why?
|
Case-Control Studies | 36 | 2024 | 22168 | 0.700 |
Why?
|
Recombinant Proteins | 8 | 2021 | 6532 | 0.690 |
Why?
|
Bone Resorption | 4 | 2019 | 723 | 0.680 |
Why?
|
Adrenal Hyperplasia, Congenital | 2 | 2012 | 104 | 0.680 |
Why?
|
Body Height | 8 | 2011 | 1570 | 0.680 |
Why?
|
Growth Hormone | 5 | 2020 | 569 | 0.680 |
Why?
|
Dehydroepiandrosterone Sulfate | 5 | 2022 | 241 | 0.670 |
Why?
|
Finite Element Analysis | 8 | 2019 | 437 | 0.660 |
Why?
|
Hypogonadism | 6 | 2014 | 798 | 0.660 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2015 | 600 | 0.650 |
Why?
|
Endocrine System Diseases | 4 | 2020 | 249 | 0.650 |
Why?
|
Hip | 3 | 2020 | 255 | 0.640 |
Why?
|
Adipokines | 2 | 2011 | 310 | 0.640 |
Why?
|
Femur | 6 | 2020 | 1307 | 0.630 |
Why?
|
Endocrine System | 2 | 2017 | 114 | 0.620 |
Why?
|
Cushing Syndrome | 2 | 2011 | 241 | 0.620 |
Why?
|
Bone Density Conservation Agents | 7 | 2022 | 795 | 0.620 |
Why?
|
Collagen Type I | 6 | 2015 | 616 | 0.610 |
Why?
|
Age Determination by Skeleton | 7 | 2018 | 126 | 0.590 |
Why?
|
Bone Diseases, Metabolic | 5 | 2019 | 409 | 0.590 |
Why?
|
Eating | 12 | 2024 | 1538 | 0.580 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2013 | 841 | 0.580 |
Why?
|
Gynecomastia | 2 | 2016 | 87 | 0.570 |
Why?
|
Musculoskeletal System | 1 | 2019 | 188 | 0.570 |
Why?
|
Metformin | 2 | 2016 | 906 | 0.560 |
Why?
|
Hyperthyroidism | 3 | 2015 | 292 | 0.550 |
Why?
|
Receptors, Calcitriol | 1 | 2019 | 360 | 0.550 |
Why?
|
Nutritional Status | 5 | 2018 | 1613 | 0.540 |
Why?
|
Anxiety | 8 | 2024 | 4572 | 0.540 |
Why?
|
Menstrual Cycle | 4 | 2016 | 539 | 0.510 |
Why?
|
Hunger | 4 | 2021 | 206 | 0.510 |
Why?
|
Fetal Macrosomia | 1 | 2016 | 141 | 0.500 |
Why?
|
Medicine | 1 | 2023 | 941 | 0.500 |
Why?
|
Energy Metabolism | 9 | 2024 | 2881 | 0.490 |
Why?
|
Fasting | 8 | 2024 | 1602 | 0.490 |
Why?
|
Verbal Learning | 1 | 2017 | 463 | 0.480 |
Why?
|
Pituitary Hormones | 2 | 2014 | 182 | 0.480 |
Why?
|
gamma-Aminobutyric Acid | 5 | 2024 | 1140 | 0.470 |
Why?
|
Osteogenesis | 5 | 2020 | 1273 | 0.470 |
Why?
|
Calcium | 5 | 2023 | 5727 | 0.470 |
Why?
|
Male | 86 | 2024 | 360736 | 0.460 |
Why?
|
Testicular Hormones | 3 | 2003 | 188 | 0.460 |
Why?
|
Attitude | 2 | 2018 | 775 | 0.450 |
Why?
|
Fibronectins | 2 | 2014 | 723 | 0.440 |
Why?
|
Lipids | 3 | 2013 | 3340 | 0.440 |
Why?
|
Insulin | 11 | 2023 | 6602 | 0.440 |
Why?
|
Dietary Fiber | 2 | 2015 | 759 | 0.440 |
Why?
|
Graves Disease | 1 | 2015 | 238 | 0.440 |
Why?
|
Reference Values | 13 | 2019 | 4921 | 0.440 |
Why?
|
Diet, Reducing | 1 | 2017 | 485 | 0.430 |
Why?
|
Binge-Eating Disorder | 3 | 2022 | 147 | 0.430 |
Why?
|
Administration, Cutaneous | 5 | 2021 | 713 | 0.430 |
Why?
|
Suicidal Ideation | 2 | 2020 | 1444 | 0.430 |
Why?
|
Hormones | 7 | 2018 | 869 | 0.430 |
Why?
|
Bone Development | 2 | 2013 | 472 | 0.430 |
Why?
|
Adipose Tissue, Brown | 2 | 2016 | 764 | 0.420 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2012 | 21 | 0.420 |
Why?
|
Adrenarche | 1 | 2012 | 6 | 0.420 |
Why?
|
Fractures, Stress | 1 | 2015 | 202 | 0.420 |
Why?
|
Executive Function | 2 | 2021 | 1389 | 0.410 |
Why?
|
Depressive Disorder, Major | 7 | 2024 | 4760 | 0.400 |
Why?
|
Hip Joint | 4 | 2020 | 1013 | 0.400 |
Why?
|
Glycoproteins | 4 | 2003 | 2208 | 0.400 |
Why?
|
Calcium, Dietary | 4 | 2019 | 529 | 0.400 |
Why?
|
Hypothalamus | 2 | 2018 | 999 | 0.400 |
Why?
|
Overweight | 7 | 2023 | 2413 | 0.400 |
Why?
|
Hypoglycemic Agents | 2 | 2016 | 3081 | 0.390 |
Why?
|
Dwarfism, Pituitary | 3 | 2020 | 39 | 0.390 |
Why?
|
Growth Inhibitors | 2 | 2003 | 378 | 0.380 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2013 | 1651 | 0.370 |
Why?
|
Craniopharyngioma | 2 | 2021 | 277 | 0.370 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2011 | 107 | 0.370 |
Why?
|
Sports Medicine | 4 | 2021 | 240 | 0.370 |
Why?
|
Mental Recall | 1 | 2017 | 1214 | 0.370 |
Why?
|
Birth Weight | 2 | 2016 | 2100 | 0.360 |
Why?
|
Blood Glucose | 8 | 2020 | 6391 | 0.340 |
Why?
|
Postprandial Period | 4 | 2024 | 315 | 0.340 |
Why?
|
Health | 2 | 2012 | 398 | 0.340 |
Why?
|
Genetic Markers | 2 | 2013 | 2613 | 0.340 |
Why?
|
Dietary Proteins | 2 | 2019 | 952 | 0.340 |
Why?
|
Adiposity | 5 | 2019 | 1877 | 0.330 |
Why?
|
C-Reactive Protein | 6 | 2024 | 3823 | 0.330 |
Why?
|
Body Dysmorphic Disorders | 1 | 2013 | 243 | 0.330 |
Why?
|
Dietary Fats | 4 | 2017 | 1994 | 0.320 |
Why?
|
Parathyroid Hormone | 2 | 2012 | 1803 | 0.320 |
Why?
|
Progesterone | 1 | 2013 | 742 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2020 | 3441 | 0.310 |
Why?
|
Adiponectin | 5 | 2019 | 1113 | 0.310 |
Why?
|
Anthropometry | 5 | 2014 | 1349 | 0.300 |
Why?
|
Reward | 3 | 2024 | 971 | 0.300 |
Why?
|
Weight-Bearing | 5 | 2019 | 532 | 0.300 |
Why?
|
Nutrition Assessment | 2 | 2009 | 728 | 0.300 |
Why?
|
Rickets | 1 | 2008 | 70 | 0.300 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15498 | 0.290 |
Why?
|
Breast | 1 | 2016 | 1966 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 17 | 2023 | 20556 | 0.280 |
Why?
|
Dietary Carbohydrates | 2 | 2009 | 891 | 0.280 |
Why?
|
Glucose | 4 | 2023 | 4347 | 0.270 |
Why?
|
Regression Analysis | 8 | 2012 | 6343 | 0.270 |
Why?
|
Administration, Oral | 5 | 2020 | 4016 | 0.270 |
Why?
|
Adolescent Behavior | 2 | 2019 | 1186 | 0.270 |
Why?
|
Iodine Radioisotopes | 2 | 2010 | 1033 | 0.270 |
Why?
|
Peptide Fragments | 6 | 2020 | 5115 | 0.260 |
Why?
|
Hypothyroidism | 2 | 2010 | 667 | 0.260 |
Why?
|
Dietary Supplements | 3 | 2019 | 3414 | 0.260 |
Why?
|
Retrospective Studies | 26 | 2024 | 80582 | 0.260 |
Why?
|
Gyrus Cinguli | 4 | 2024 | 1115 | 0.250 |
Why?
|
Diet Records | 3 | 2015 | 427 | 0.250 |
Why?
|
Comorbidity | 8 | 2024 | 10498 | 0.250 |
Why?
|
Cryptorchidism | 2 | 2003 | 151 | 0.240 |
Why?
|
Depression | 5 | 2021 | 8122 | 0.240 |
Why?
|
Gonadal Hormones | 3 | 2023 | 30 | 0.240 |
Why?
|
Diet | 4 | 2018 | 8074 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.240 |
Why?
|
Health Status Disparities | 1 | 2016 | 1852 | 0.240 |
Why?
|
Attitude to Health | 1 | 2013 | 2025 | 0.230 |
Why?
|
Stress, Psychological | 3 | 2024 | 4477 | 0.230 |
Why?
|
Virilism | 2 | 2003 | 28 | 0.230 |
Why?
|
Cortisone | 1 | 2024 | 87 | 0.230 |
Why?
|
Psychotropic Drugs | 2 | 2012 | 888 | 0.230 |
Why?
|
Bradycardia | 2 | 2008 | 299 | 0.230 |
Why?
|
Hyperprolactinemia | 1 | 2004 | 124 | 0.220 |
Why?
|
Prolactin | 2 | 2008 | 625 | 0.220 |
Why?
|
Appetite Regulation | 2 | 2019 | 84 | 0.220 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 602 | 0.220 |
Why?
|
Faculty, Medical | 2 | 2023 | 1202 | 0.220 |
Why?
|
Sex Characteristics | 6 | 2024 | 2637 | 0.210 |
Why?
|
Menstruation Disturbances | 2 | 2022 | 143 | 0.210 |
Why?
|
Emotions | 1 | 2015 | 2739 | 0.210 |
Why?
|
Hormone Replacement Therapy | 3 | 2016 | 751 | 0.210 |
Why?
|
Receptors, Opioid, mu | 1 | 2024 | 167 | 0.210 |
Why?
|
Receptors, Opioid, kappa | 1 | 2024 | 138 | 0.210 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2010 | 416 | 0.210 |
Why?
|
Fibroblast Growth Factors | 3 | 2014 | 867 | 0.210 |
Why?
|
Prognosis | 11 | 2021 | 29620 | 0.210 |
Why?
|
Administration, Intranasal | 1 | 2024 | 477 | 0.200 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2947 | 0.200 |
Why?
|
Prevalence | 8 | 2021 | 15717 | 0.200 |
Why?
|
Longitudinal Studies | 8 | 2023 | 14599 | 0.200 |
Why?
|
Gonadotropins | 3 | 2010 | 241 | 0.200 |
Why?
|
Cholecystokinin | 1 | 2022 | 117 | 0.200 |
Why?
|
Anxiety Disorders | 1 | 2013 | 2717 | 0.200 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2898 | 0.200 |
Why?
|
Malnutrition | 2 | 2006 | 644 | 0.190 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39117 | 0.190 |
Why?
|
Pituitary Neoplasms | 3 | 2021 | 1324 | 0.190 |
Why?
|
Membrane Proteins | 3 | 2013 | 7856 | 0.190 |
Why?
|
Penis | 1 | 2002 | 212 | 0.190 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2574 | 0.190 |
Why?
|
Body Fat Distribution | 3 | 2012 | 245 | 0.190 |
Why?
|
Pediatrics | 1 | 2016 | 3595 | 0.190 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1265 | 0.190 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1179 | 0.190 |
Why?
|
Basal Metabolism | 2 | 2016 | 161 | 0.190 |
Why?
|
Wrist Injuries | 1 | 2023 | 214 | 0.190 |
Why?
|
Social Responsibility | 1 | 2023 | 386 | 0.180 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1871 | 0.180 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.180 |
Why?
|
Spinal Fractures | 2 | 2019 | 705 | 0.180 |
Why?
|
Adrenal Glands | 3 | 2019 | 552 | 0.180 |
Why?
|
Psychopathology | 2 | 2023 | 431 | 0.180 |
Why?
|
Child, Preschool | 12 | 2019 | 42254 | 0.180 |
Why?
|
Faculty | 1 | 2023 | 383 | 0.180 |
Why?
|
Calorimetry, Indirect | 2 | 2014 | 174 | 0.180 |
Why?
|
Pelvic Bones | 2 | 2020 | 270 | 0.180 |
Why?
|
Pituitary Gland | 2 | 2018 | 635 | 0.180 |
Why?
|
Mitochondria | 1 | 2013 | 3623 | 0.180 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2013 | 550 | 0.170 |
Why?
|
Femur Neck | 3 | 2020 | 314 | 0.170 |
Why?
|
Bulimia | 1 | 2022 | 400 | 0.170 |
Why?
|
Hydatidiform Mole | 1 | 2002 | 255 | 0.170 |
Why?
|
Turner Syndrome | 2 | 2011 | 130 | 0.170 |
Why?
|
Prospective Studies | 13 | 2023 | 54415 | 0.170 |
Why?
|
Diet, Protein-Restricted | 1 | 2019 | 73 | 0.160 |
Why?
|
Drug Administration Routes | 1 | 2019 | 150 | 0.160 |
Why?
|
Desogestrel | 1 | 2018 | 17 | 0.160 |
Why?
|
Nutrition Surveys | 1 | 2006 | 1728 | 0.160 |
Why?
|
Contraceptive Agents, Female | 1 | 2020 | 118 | 0.160 |
Why?
|
Intrauterine Devices | 1 | 2020 | 113 | 0.160 |
Why?
|
Androgens | 4 | 2019 | 1286 | 0.160 |
Why?
|
Sexual Harassment | 1 | 2019 | 82 | 0.160 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.160 |
Why?
|
Area Under Curve | 4 | 2012 | 1638 | 0.160 |
Why?
|
Dwarfism | 1 | 2019 | 138 | 0.160 |
Why?
|
Transdermal Patch | 1 | 2018 | 51 | 0.160 |
Why?
|
Energy Intake | 3 | 2024 | 2134 | 0.160 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.150 |
Why?
|
Liver | 1 | 2014 | 7532 | 0.150 |
Why?
|
Ethinyl Estradiol | 1 | 2018 | 113 | 0.150 |
Why?
|
Preoperative Period | 1 | 2020 | 552 | 0.150 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1377 | 0.150 |
Why?
|
Radioimmunoassay | 4 | 2010 | 865 | 0.150 |
Why?
|
Triglycerides | 3 | 2013 | 2460 | 0.150 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 11 | 2024 | 36423 | 0.140 |
Why?
|
E-Selectin | 2 | 2010 | 576 | 0.140 |
Why?
|
Fast Foods | 1 | 2019 | 210 | 0.140 |
Why?
|
Peptides | 4 | 2015 | 4345 | 0.140 |
Why?
|
Risk Factors | 12 | 2020 | 74167 | 0.140 |
Why?
|
Premenopause | 2 | 2019 | 1039 | 0.140 |
Why?
|
Subcutaneous Fat | 2 | 2011 | 393 | 0.140 |
Why?
|
Forearm | 1 | 2019 | 427 | 0.140 |
Why?
|
Recovery of Function | 3 | 2014 | 2977 | 0.140 |
Why?
|
Growth | 2 | 2009 | 365 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 2 | 2013 | 702 | 0.140 |
Why?
|
Nutritive Value | 1 | 2019 | 350 | 0.130 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1148 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2024 | 3769 | 0.130 |
Why?
|
Phytic Acid | 1 | 2015 | 22 | 0.130 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2021 | 1988 | 0.130 |
Why?
|
Vitamins | 2 | 2019 | 1634 | 0.130 |
Why?
|
Aging | 3 | 2024 | 8705 | 0.130 |
Why?
|
Phytoestrogens | 1 | 2015 | 59 | 0.130 |
Why?
|
Cranial Irradiation | 1 | 2018 | 390 | 0.130 |
Why?
|
Treatment Outcome | 12 | 2024 | 64651 | 0.130 |
Why?
|
Adenoma | 2 | 2021 | 2160 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 491 | 0.130 |
Why?
|
Sex Distribution | 2 | 2013 | 2281 | 0.130 |
Why?
|
Double-Blind Method | 5 | 2024 | 12330 | 0.130 |
Why?
|
Drive | 1 | 2015 | 34 | 0.130 |
Why?
|
Postoperative Period | 1 | 2020 | 1815 | 0.120 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2015 | 34 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12058 | 0.120 |
Why?
|
Fractures, Spontaneous | 1 | 2016 | 231 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2821 | 0.120 |
Why?
|
Italy | 1 | 2017 | 843 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2015 | 190 | 0.120 |
Why?
|
Technetium | 1 | 2015 | 322 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 12143 | 0.120 |
Why?
|
Middle Aged | 25 | 2024 | 220826 | 0.120 |
Why?
|
Object Attachment | 1 | 2017 | 326 | 0.120 |
Why?
|
Diphosphonates | 2 | 2011 | 636 | 0.120 |
Why?
|
Thyroid Hormones | 2 | 2011 | 404 | 0.120 |
Why?
|
Eclampsia | 1 | 1994 | 56 | 0.120 |
Why?
|
Mentors | 1 | 2019 | 660 | 0.110 |
Why?
|
Ultrasonography, Mammary | 1 | 2016 | 239 | 0.110 |
Why?
|
Depressive Disorder | 3 | 2016 | 3728 | 0.110 |
Why?
|
Ovary | 2 | 2009 | 959 | 0.110 |
Why?
|
Diet Surveys | 1 | 2018 | 1162 | 0.110 |
Why?
|
Bulimia Nervosa | 1 | 2016 | 206 | 0.110 |
Why?
|
Vegetables | 1 | 2019 | 1196 | 0.110 |
Why?
|
Physical Endurance | 1 | 2016 | 366 | 0.110 |
Why?
|
Child Behavior | 1 | 2019 | 847 | 0.110 |
Why?
|
Calcium-Binding Proteins | 3 | 2013 | 1069 | 0.110 |
Why?
|
Hip Fractures | 2 | 2020 | 988 | 0.110 |
Why?
|
Physicians, Women | 1 | 2019 | 508 | 0.110 |
Why?
|
Thyroid Gland | 2 | 2010 | 1168 | 0.110 |
Why?
|
Transaminases | 1 | 2014 | 198 | 0.110 |
Why?
|
Steroids | 2 | 2009 | 929 | 0.110 |
Why?
|
Career Choice | 1 | 2019 | 756 | 0.110 |
Why?
|
Thorax | 2 | 2008 | 555 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2002 | 1420 | 0.110 |
Why?
|
Aspartate Aminotransferases | 1 | 2014 | 416 | 0.110 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15838 | 0.110 |
Why?
|
Ideal Body Weight | 1 | 2012 | 27 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 6309 | 0.100 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2015 | 540 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2020 | 868 | 0.100 |
Why?
|
Liver Function Tests | 1 | 2014 | 523 | 0.100 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 12970 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 518 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15262 | 0.100 |
Why?
|
Anti-Mullerian Hormone | 3 | 2003 | 407 | 0.100 |
Why?
|
Alanine Transaminase | 1 | 2014 | 603 | 0.100 |
Why?
|
Teriparatide | 1 | 2014 | 227 | 0.100 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 141 | 0.100 |
Why?
|
Thyroid Function Tests | 3 | 2015 | 289 | 0.100 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 4876 | 0.100 |
Why?
|
Prolactinoma | 2 | 2010 | 114 | 0.100 |
Why?
|
Etidronic Acid | 1 | 2011 | 63 | 0.090 |
Why?
|
Luminescent Measurements | 1 | 2013 | 342 | 0.090 |
Why?
|
Pseudohypoparathyroidism | 1 | 2011 | 87 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1189 | 0.090 |
Why?
|
Satiation | 2 | 2022 | 83 | 0.090 |
Why?
|
Congenital Hypothyroidism | 1 | 2010 | 40 | 0.090 |
Why?
|
Self Report | 1 | 2022 | 3724 | 0.090 |
Why?
|
Extremities | 2 | 2008 | 867 | 0.090 |
Why?
|
Goiter | 1 | 2010 | 87 | 0.090 |
Why?
|
Disease Management | 1 | 2021 | 2507 | 0.090 |
Why?
|
Central Nervous System Cysts | 1 | 2010 | 56 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2009 | 1902 | 0.090 |
Why?
|
Fragile X Syndrome | 1 | 2011 | 116 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2024 | 5776 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1567 | 0.090 |
Why?
|
Leadership | 1 | 2019 | 1385 | 0.090 |
Why?
|
Hypothalamic Hormones | 1 | 2011 | 145 | 0.090 |
Why?
|
Gonads | 1 | 2009 | 109 | 0.080 |
Why?
|
Interleukin-6 | 3 | 2009 | 3207 | 0.080 |
Why?
|
Memory | 1 | 2019 | 2187 | 0.080 |
Why?
|
Running | 2 | 2012 | 488 | 0.080 |
Why?
|
Triiodothyronine | 2 | 2015 | 493 | 0.080 |
Why?
|
Prader-Willi Syndrome | 1 | 2010 | 78 | 0.080 |
Why?
|
Somatomedins | 1 | 2009 | 179 | 0.080 |
Why?
|
Satiety Response | 1 | 2009 | 47 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
Osteoblastoma | 1 | 2008 | 24 | 0.080 |
Why?
|
Consensus | 4 | 2021 | 3122 | 0.080 |
Why?
|
Risk Assessment | 5 | 2019 | 23990 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21012 | 0.080 |
Why?
|
Drug Resistance | 2 | 2017 | 1595 | 0.080 |
Why?
|
Cholesterol | 2 | 2008 | 2902 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2769 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10766 | 0.080 |
Why?
|
Acylation | 1 | 2008 | 96 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1222 | 0.080 |
Why?
|
Exercise Test | 2 | 2013 | 2129 | 0.080 |
Why?
|
Trabecular Meshwork | 1 | 2008 | 101 | 0.080 |
Why?
|
Sexual Development | 1 | 2008 | 40 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 151 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2005 | 2706 | 0.070 |
Why?
|
Physical Examination | 1 | 2014 | 1254 | 0.070 |
Why?
|
Social Support | 1 | 2017 | 2172 | 0.070 |
Why?
|
Time Factors | 5 | 2017 | 39975 | 0.070 |
Why?
|
Sodium | 1 | 2012 | 1588 | 0.070 |
Why?
|
Kinetics | 1 | 2015 | 6374 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 344 | 0.070 |
Why?
|
GTP-Binding Proteins | 1 | 2011 | 951 | 0.070 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2008 | 128 | 0.070 |
Why?
|
Aromatase | 1 | 2007 | 147 | 0.070 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 3687 | 0.070 |
Why?
|
Mental Disorders | 2 | 2017 | 6841 | 0.070 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 618 | 0.070 |
Why?
|
Nerve Net | 3 | 2024 | 2288 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3204 | 0.070 |
Why?
|
Patient Selection | 3 | 2019 | 4244 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8529 | 0.070 |
Why?
|
Boston | 2 | 2016 | 9330 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.060 |
Why?
|
Skull Base | 1 | 2008 | 292 | 0.060 |
Why?
|
Models, Biological | 2 | 2015 | 9469 | 0.060 |
Why?
|
Infant, Newborn | 6 | 2019 | 26212 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 785 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2009 | 1125 | 0.060 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2007 | 363 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2013 | 6019 | 0.060 |
Why?
|
Skull Base Neoplasms | 1 | 2008 | 270 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3249 | 0.060 |
Why?
|
Apolipoproteins B | 1 | 2006 | 386 | 0.060 |
Why?
|
Trace Elements | 1 | 2006 | 195 | 0.060 |
Why?
|
Muscle, Skeletal | 3 | 2019 | 4946 | 0.060 |
Why?
|
Women's Health | 1 | 2014 | 2065 | 0.060 |
Why?
|
Signal Transduction | 3 | 2019 | 23441 | 0.060 |
Why?
|
Blood Pressure | 2 | 2014 | 8487 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2008 | 592 | 0.060 |
Why?
|
Amyloid | 1 | 2009 | 841 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3224 | 0.060 |
Why?
|
Sex Factors | 4 | 2024 | 10548 | 0.060 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2008 | 474 | 0.060 |
Why?
|
Hematocrit | 1 | 2005 | 625 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7045 | 0.060 |
Why?
|
Pulsatile Flow | 1 | 2005 | 321 | 0.060 |
Why?
|
Infant | 6 | 2019 | 36205 | 0.060 |
Why?
|
Incidence | 2 | 2015 | 21341 | 0.060 |
Why?
|
Hematologic Tests | 1 | 2004 | 239 | 0.060 |
Why?
|
Menopause | 2 | 2024 | 1646 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2382 | 0.060 |
Why?
|
Periodicity | 1 | 2005 | 347 | 0.060 |
Why?
|
Gonadal Dysgenesis | 1 | 2003 | 28 | 0.050 |
Why?
|
Up-Regulation | 2 | 2009 | 4124 | 0.050 |
Why?
|
Clitoris | 1 | 2003 | 35 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1780 | 0.050 |
Why?
|
Osteoprotegerin | 1 | 2003 | 176 | 0.050 |
Why?
|
Receptors, Leptin | 1 | 2004 | 350 | 0.050 |
Why?
|
Disorders of Sex Development | 1 | 2003 | 129 | 0.050 |
Why?
|
Sertoli Cells | 1 | 2002 | 50 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9645 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1171 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2851 | 0.050 |
Why?
|
Solubility | 1 | 2004 | 1091 | 0.050 |
Why?
|
Age Distribution | 1 | 2008 | 2880 | 0.050 |
Why?
|
Pica | 1 | 2022 | 37 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10203 | 0.050 |
Why?
|
Antithyroid Agents | 1 | 2002 | 72 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2008 | 1071 | 0.050 |
Why?
|
Leucine | 1 | 2023 | 548 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1876 | 0.050 |
Why?
|
Age Factors | 5 | 2019 | 18400 | 0.050 |
Why?
|
Menarche | 1 | 2004 | 532 | 0.050 |
Why?
|
Patient Compliance | 2 | 2009 | 2690 | 0.050 |
Why?
|
Lithium | 1 | 2004 | 596 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2008 | 681 | 0.050 |
Why?
|
Cohort Studies | 3 | 2023 | 41446 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8999 | 0.050 |
Why?
|
Pregnancy | 3 | 2016 | 29862 | 0.050 |
Why?
|
Karyotyping | 1 | 2003 | 1171 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 584 | 0.050 |
Why?
|
Pilot Projects | 3 | 2020 | 8633 | 0.040 |
Why?
|
Potassium | 1 | 2004 | 1311 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2220 | 0.040 |
Why?
|
Administration, Intravaginal | 1 | 2020 | 150 | 0.040 |
Why?
|
Treatment Failure | 2 | 2019 | 2642 | 0.040 |
Why?
|
Hypertension | 1 | 2020 | 8542 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 2002 | 457 | 0.040 |
Why?
|
Diaphyses | 1 | 2019 | 65 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 219 | 0.040 |
Why?
|
Risk | 3 | 2019 | 9612 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8000 | 0.040 |
Why?
|
Thyroxine | 2 | 2015 | 668 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2021 | 299 | 0.040 |
Why?
|
Child Development | 1 | 2011 | 2305 | 0.040 |
Why?
|
Brain | 5 | 2024 | 27107 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 168 | 0.040 |
Why?
|
Germany | 1 | 2020 | 875 | 0.040 |
Why?
|
Food | 1 | 2023 | 772 | 0.040 |
Why?
|
Organ Size | 1 | 2003 | 2254 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15650 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 14026 | 0.040 |
Why?
|
Corpus Striatum | 1 | 2024 | 1235 | 0.040 |
Why?
|
Euthyroid Sick Syndromes | 1 | 2017 | 14 | 0.040 |
Why?
|
Brain Mapping | 2 | 2024 | 6626 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2332 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58956 | 0.040 |
Why?
|
Independent Living | 1 | 2021 | 579 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 6966 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7389 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20093 | 0.040 |
Why?
|
Abdomen | 1 | 2003 | 1128 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9031 | 0.030 |
Why?
|
Hippocampus | 2 | 2020 | 3763 | 0.030 |
Why?
|
United States | 4 | 2021 | 72339 | 0.030 |
Why?
|
Disease Progression | 1 | 2014 | 13502 | 0.030 |
Why?
|
Blood Chemical Analysis | 2 | 2008 | 437 | 0.030 |
Why?
|
Memory Disorders | 1 | 2024 | 1198 | 0.030 |
Why?
|
Outpatients | 1 | 2004 | 1597 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2006 | 2092 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2002 | 1241 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2711 | 0.030 |
Why?
|
Animals | 3 | 2020 | 168441 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5789 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2018 | 629 | 0.030 |
Why?
|
Reproductive Medicine | 1 | 2017 | 99 | 0.030 |
Why?
|
Contraceptives, Oral | 2 | 2009 | 554 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11902 | 0.030 |
Why?
|
Aged | 4 | 2021 | 169235 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2004 | 1906 | 0.030 |
Why?
|
Learning | 1 | 2024 | 1740 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3889 | 0.030 |
Why?
|
Indiana | 1 | 2014 | 92 | 0.030 |
Why?
|
Motivation | 1 | 2024 | 2006 | 0.030 |
Why?
|
San Francisco | 1 | 2014 | 162 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2020 | 1315 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14664 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4014 | 0.030 |
Why?
|
Heart Rate | 1 | 2004 | 4198 | 0.030 |
Why?
|
Chemical Phenomena | 1 | 2013 | 508 | 0.030 |
Why?
|
Neural Pathways | 1 | 2024 | 3057 | 0.030 |
Why?
|
Athletic Performance | 1 | 2014 | 111 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2019 | 982 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1403 | 0.030 |
Why?
|
Golf | 1 | 2012 | 16 | 0.030 |
Why?
|
Wrestling | 1 | 2012 | 19 | 0.030 |
Why?
|
Porosity | 1 | 2013 | 349 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2010 | 6231 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4852 | 0.020 |
Why?
|
Parity | 1 | 1994 | 927 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 455 | 0.020 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.020 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2010 | 49 | 0.020 |
Why?
|
Medical History Taking | 1 | 2014 | 773 | 0.020 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2009 | 42 | 0.020 |
Why?
|
Hyponatremia | 1 | 2012 | 279 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1476 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2009 | 68 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2399 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 2004 | 3223 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5246 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
Fecal Impaction | 1 | 2008 | 32 | 0.020 |
Why?
|
Fats | 1 | 2009 | 99 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2019 | 2218 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2010 | 393 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2014 | 908 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 2009 | 205 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 2009 | 258 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2008 | 127 | 0.020 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2010 | 179 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6485 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2011 | 1463 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2004 | 5091 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2010 | 386 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1535 | 0.020 |
Why?
|
Thyrotropin | 1 | 2010 | 834 | 0.020 |
Why?
|
Universities | 1 | 2012 | 993 | 0.020 |
Why?
|
Growth Plate | 1 | 2008 | 274 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1188 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2918 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6238 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2007 | 256 | 0.020 |
Why?
|
Schizophrenia | 1 | 2004 | 6937 | 0.020 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1129 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6986 | 0.020 |
Why?
|
Body Image | 1 | 2010 | 638 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1863 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 2008 | 258 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7956 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8832 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2010 | 907 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3905 | 0.020 |
Why?
|
Phenotype | 1 | 2003 | 16606 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1089 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2010 | 1271 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5036 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 2007 | 642 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 1994 | 2920 | 0.010 |
Why?
|
Water | 1 | 2010 | 1410 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1669 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 675 | 0.010 |
Why?
|
Mesenchymal Stem Cells | 1 | 2013 | 1642 | 0.010 |
Why?
|
Patient Care Team | 1 | 2014 | 2523 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1525 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2208 | 0.010 |
Why?
|
Recurrence | 1 | 1994 | 8469 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5869 | 0.010 |
Why?
|
Students | 1 | 2012 | 1741 | 0.010 |
Why?
|
Self Concept | 1 | 2007 | 1043 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3268 | 0.010 |
Why?
|
Health Status | 1 | 2014 | 4075 | 0.010 |
Why?
|
Headache | 1 | 2008 | 1256 | 0.010 |
Why?
|
Social Behavior | 1 | 2007 | 1134 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3589 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2803 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2012 | 2897 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6178 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1436 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4063 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4589 | 0.010 |
Why?
|
Psychotherapy | 1 | 2008 | 1647 | 0.010 |
Why?
|
Proteins | 1 | 2014 | 6032 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2012 | 3068 | 0.010 |
Why?
|
Phosphates | 1 | 2002 | 770 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5970 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15605 | 0.010 |
Why?
|
Laparoscopy | 1 | 2009 | 2035 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11073 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5428 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12450 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11526 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9320 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7595 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14409 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12796 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 30045 | 0.000 |
Why?
|
Mice | 1 | 2008 | 81509 | 0.000 |
Why?
|